Açıklama
Clinical evidence for PRP efficacy in primary cicatricial alopecias is summarized, with treatment parameters and outcomes tabulated from the available studies. Results suggest PRP may offer benefit in select cases of scarring hair loss.
Figure 3
ChartSource Paper
Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A systematic review.Cite This Figure
![Figure 3: Clinical evidence for PRP efficacy in primary cicatricial alopecias is summarized, with treatment parameters and outcomes tabulated from the available studies. Results suggest PRP may offer benefit in select cases of scarring hair loss.]() > Source: Kasama Tejapira et al. "Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A sys." *Frontiers in medicine*, 2022. PMID: [36507528](https://pubmed.ncbi.nlm.nih.gov/36507528/)
<figure> <img src="" alt="Clinical evidence for PRP efficacy in primary cicatricial alopecias is summarized, with treatment parameters and outcomes tabulated from the available studies. Results suggest PRP may offer benefit in select cases of scarring hair loss." /> <figcaption>Figure 3. Clinical evidence for PRP efficacy in primary cicatricial alopecias is summarized, with treatment parameters and outcomes tabulated from the available studies. Results suggest PRP may offer benefit in select cases of scarring hair loss.<br> Source: Kasama Tejapira et al. "Platelet-rich plasma in alopecia areata and primary cicatricial alopecias: A sys." <em>Frontiers in medicine</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36507528/">36507528</a></figcaption> </figure>